raloxifene hydrochloride has been researched along with Alveolar Bone Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, M; Ichimaru, R; Inada, M; Matsumoto, C; Miyaura, C; Murphy, G; Nagase, H; Numabe, Y; Tominari, T; Watanabe, K; Yoshinouchi, S | 1 |
1 other study(ies) available for raloxifene hydrochloride and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Raloxifene reduces the risk of local alveolar bone destruction in a mouse model of periodontitis combined with systemic postmenopausal osteoporosis.
Topics: Alveolar Bone Loss; Animals; Bone Density; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Female; Humans; Mice; Osteoblasts; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2018 |